You are here

Roche

Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies

TheStreet.com

Tue, 11/29/16 - 09:49 am

Alzheimer's disease

$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market

Motley Fool

Mon, 11/21/16 - 02:35 pm

Alzheimer's disease

BACE inhibitors

Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class

Market Realist

Mon, 11/21/16 - 11:39 am

Bristol-Myers Squibb

Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing

Fierce Pharma

Wed, 11/16/16 - 09:57 am

Roche forms 21-site I/O R&D network, commits $100M

Fierce Biotech

Tue, 11/15/16 - 10:10 am

Roche flags early success for Tecentriq combos, hustles into PhIIIs

Endpoints

Mon, 11/7/16 - 09:10 pm

clinical trials

Safety issues with Roche drug good for Novo Nordisk

BioPharma Dive

Thu, 11/3/16 - 01:30 pm

If Roche's Ocrevus is approved, the already competitive MS market will gain another player

Medical Marketing and Media

Mon, 10/24/16 - 11:54 pm

multiple sclerosis

With no big M&A on tap, Novartis presses pause on $12B-plus Roche stake sale

Fierce Pharma

Mon, 10/24/16 - 11:51 pm

Roche adjusts Avastin franchise defense plans as PhII successor fails a key study

Endpoints

Fri, 10/21/16 - 10:01 am

Earnings guide: A preview of 9 big pharmas in Q3

BioPharma Dive

Wed, 10/19/16 - 11:52 am

Bristol-Myers Squibb

Roche's lung cancer drug wins U.S. approval

Yahoo/Reuters

Tue, 10/18/16 - 10:27 pm

non-small cell lung cancer

Clinical trial roundup 2015 (infographic)

CP Wire

Tue, 10/18/16 - 10:21 am

clinical trials

Roche, AbbVie: Venclyxto Receives Positive Opinion From Committee

Yahoo/GuruFocus

Sat, 10/15/16 - 12:23 pm

chronic lymphocytic leukemia

Roche lung cancer drug success adds to pressure on Bristol

Yahoo/Reuters

Mon, 10/10/16 - 09:14 am

3 Critical FDA Decisions You Can't Afford to Miss

Motley Fool

Tue, 09/27/16 - 10:13 pm

Vertex Pharmaceuticals

Novartis's Zykadia gets positive results, faces Roche pressure

Yahoo/Reuters

Fri, 09/23/16 - 10:07 pm

non-small cell lung cancer

Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA

Endpoints

Fri, 09/23/16 - 11:47 am

non-small cell lung cancer

rheumatoid arthritis

Roche To Topple Novartis As Industry's Biggest Seller

Seeking Alpha

Sun, 09/18/16 - 10:03 am

Roche’s megablockbuster MS candidate ocrelizumab posts promising head-to-head data

Endpoints

Wed, 09/14/16 - 11:42 pm

multiple sclerosis

Pages